$OPXA News Opexa, BreitBurn, Hudson Pacific pr
Post# of 144499
Posted On: 06/24/2014 10:27:32 AM
$OPXA News
Opexa, BreitBurn, Hudson Pacific price offerings 1:07 p.m. Feb. 7, 2013 - MarketWatch.com
Opexa Therapeutics grants drug license to Merck 10:38 a.m. Feb. 5, 2013 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 5:27 p.m. Jan. 5, 2011 - MarketWatch
Glaxo, Opexa in drug sector spotlight 1:15 p.m. Jan. 5, 2011 - Val Brickates Kennedy
Opexa soars on talks with FDA over MS drug 11:56 a.m. Jan. 5, 2011 - William Spain
Avanir, Opexa gain ahead of presentations 3:16 p.m. April 6, 2010 - Val Brickates Kennedy
Opexa Is Personalizing The Treatment Of Autoimmune Disease 9:24 a.m. June 3, 2014 - Seeking Alpha
Think Like A Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives On 6 Exciting Biotechs 3:29 a.m. May 16, 2014 - Seeking Alpha
10-Q: OPEXA THERAPEUTICS, INC. 4:09 p.m. May 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Opexa Therapeutics: An Optimal Buyout Candidate Pending Successful Topline Results From Abili-T 9:00 a.m. April 30, 2014 - Seeking Alpha
OXiGENE Incorporated: An Undervalued Opportunity In Biopharmaceuticals 1:35 p.m. March 25, 2014 - Seeking Alpha
Opexa Therapeutics: A Long-Term Perspective For Price Appreciation 12:04 p.m. March 10, 2014 - Seeking Alpha
Will Opexa Become A Multi Bagger? 1:19 p.m. Feb. 21, 2014 - Seeking Alpha
Weekly CFO Buys Highlight 12:32 p.m. Aug. 19, 2013 - GuruFocus.com
9 Compelling Reasons To Buy Opexa Therapeutics Right Now 12:44 p.m. Aug. 15, 2013 - Seeking Alpha
The Highs And The Lows: Opexa's Changing Market Trends 2:49 p.m. Aug. 12, 2013 - Seeking Alpha
Closing Bell for Thursday on Wall Street: Markets Open Lower, Close with Gains 3:30 p.m. Aug. 8, 2013 - 247WallSt.com
Opexa Morphs from Mystery Mega-Rally to Money Killer 9:56 a.m. Aug. 8, 2013 - 247WallSt.com
Closing Bell for Wednesday on Wall Street: Markets Lower at Open, Lower at Close 3:36 p.m. Aug. 7, 2013 - 247WallSt.com
Biotech Movers: Optimer Rockets, Ziopharm in Free Fall 3:25 a.m. April 8, 2013 - InvestorPlace.com
Chelsea Therapeutics: A Shoe-In For FDA Approval, Shares Could Double From Here 9:02 p.m. March 26, 2013 - Seeking Alpha
Market Close: Big Winners & Losers for March 26, 2013 (LEDS, BVX, PTEK, OPXA, LOGM, ZIOP, STXS, GMAN, GMXR, PRTS) 3:35 p.m. March 26, 2013 - 247WallSt.com
Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors 9:01 a.m. March 26, 2013 - Seeking Alpha
Opexa Therapeutics Poised For Breakout 10:39 a.m. March 12, 2013 - Seeking Alpha
Market Close: Today’s Big Winners & Losers (OSIR, END, APP, HCI, PTEK, RDIB, MELA, OPXA, ACUR, RWC) 4:56 p.m. March 6, 2013 - 247WallSt.com
Opexa Therapeutics Gets Attention From Institutions, Should It Get Yours? 3:22 p.m. Feb. 14, 2013 - Seeking Alpha
Top Gainers Technical Data -- Research on SolarCity, Clean Energy Fuel, Opexa Therapeutics, and Atossa Genetics 7:50 a.m. May 30, 2014 - PR Newswire - PRF
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg 8:38 a.m. May 29, 2014 - GlobeNewswire
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis 8:02 a.m. May 13, 2014 - BusinessWire - BZX
Opexa Therapeutics Announces News Release and Conference Call to Discuss First Quarter 2014 Financial Results 8:02 a.m. May 12, 2014 - BusinessWire - BZX
Global Stem Cell Umbilical Cord Blood (UCB) Market (Storage Service, Therapeutics, Application, Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 - 2020 12:33 p.m. April 23, 2014 - PR Newswire - PRF
Opexa Therapeutics to Attend the American Academy of Neurology Annual Meeting 8:01 a.m. April 22, 2014 - BusinessWire - BZX
RedChip Global Online CEO Conference, April 23-24, Featuring Presentations From 30+ Small-Cap Companies 10:24 a.m. April 21, 2014 - GlobeNewswire
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg 10:19 a.m. April 10, 2014 - GlobeNewswire
Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa 8:00 a.m. March 21, 2014 - PR Newswire - PRF
Opexa Therapeutics Appoints Prof. Hans-Peter Hartung and Timothy Barabe to the Board of Directors 8:02 a.m. March 20, 2014 - BusinessWire - BZX
Opexa Therapeutics Reports Year End 2013 Financial Results and Provides Corporate Update 5:20 p.m. Feb. 27, 2014 - BusinessWire - BZX
Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Year End 2013 Financial Results 9:02 a.m. Feb. 26, 2014 - BusinessWire - BZX
DELiA*s Path to Recovery Hampered By Sluggish Retail Marketplace 11:04 a.m. Feb. 24, 2014 - ACCESSWIRE
Opexa Therapeutics CEO to Present at the 2014 Leerink Global Healthcare Conference 3:17 p.m. Feb. 11, 2014 - BusinessWire - BZX
Opexa Therapeutics to Present at the 16th Annual BIO CEO & Investor Conference 10:00 a.m. Jan. 29, 2014 - BusinessWire - BZX
Opexa Therapeutics Chief Scientific Officer Invited as Guest Speaker at the Phacilitate Cell & Gene Therapy Forum 10:01 a.m. Jan. 23, 2014 - BusinessWire - BZX
Opexa Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 11:18 a.m. Dec. 23, 2013 - BusinessWire
Opexa Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock 10:15 p.m. Dec. 17, 2013 - BusinessWire
Opexa Therapeutics, Inc. Announces Proposed Public Offering of Common Stock 5:33 p.m. Dec. 17, 2013 - BusinessWire
Opexa Therapeutics Provides MS Trial Enrollment Update; 70% of Patients Enrolled 9:00 a.m. Dec. 16, 2013 - BusinessWire
Opexa, BreitBurn, Hudson Pacific price offerings 1:07 p.m. Feb. 7, 2013 - MarketWatch.com
Opexa Therapeutics grants drug license to Merck 10:38 a.m. Feb. 5, 2013 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 5:27 p.m. Jan. 5, 2011 - MarketWatch
Glaxo, Opexa in drug sector spotlight 1:15 p.m. Jan. 5, 2011 - Val Brickates Kennedy
Opexa soars on talks with FDA over MS drug 11:56 a.m. Jan. 5, 2011 - William Spain
Avanir, Opexa gain ahead of presentations 3:16 p.m. April 6, 2010 - Val Brickates Kennedy
Opexa Is Personalizing The Treatment Of Autoimmune Disease 9:24 a.m. June 3, 2014 - Seeking Alpha
Think Like A Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives On 6 Exciting Biotechs 3:29 a.m. May 16, 2014 - Seeking Alpha
10-Q: OPEXA THERAPEUTICS, INC. 4:09 p.m. May 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Opexa Therapeutics: An Optimal Buyout Candidate Pending Successful Topline Results From Abili-T 9:00 a.m. April 30, 2014 - Seeking Alpha
OXiGENE Incorporated: An Undervalued Opportunity In Biopharmaceuticals 1:35 p.m. March 25, 2014 - Seeking Alpha
Opexa Therapeutics: A Long-Term Perspective For Price Appreciation 12:04 p.m. March 10, 2014 - Seeking Alpha
Will Opexa Become A Multi Bagger? 1:19 p.m. Feb. 21, 2014 - Seeking Alpha
Weekly CFO Buys Highlight 12:32 p.m. Aug. 19, 2013 - GuruFocus.com
9 Compelling Reasons To Buy Opexa Therapeutics Right Now 12:44 p.m. Aug. 15, 2013 - Seeking Alpha
The Highs And The Lows: Opexa's Changing Market Trends 2:49 p.m. Aug. 12, 2013 - Seeking Alpha
Closing Bell for Thursday on Wall Street: Markets Open Lower, Close with Gains 3:30 p.m. Aug. 8, 2013 - 247WallSt.com
Opexa Morphs from Mystery Mega-Rally to Money Killer 9:56 a.m. Aug. 8, 2013 - 247WallSt.com
Closing Bell for Wednesday on Wall Street: Markets Lower at Open, Lower at Close 3:36 p.m. Aug. 7, 2013 - 247WallSt.com
Biotech Movers: Optimer Rockets, Ziopharm in Free Fall 3:25 a.m. April 8, 2013 - InvestorPlace.com
Chelsea Therapeutics: A Shoe-In For FDA Approval, Shares Could Double From Here 9:02 p.m. March 26, 2013 - Seeking Alpha
Market Close: Big Winners & Losers for March 26, 2013 (LEDS, BVX, PTEK, OPXA, LOGM, ZIOP, STXS, GMAN, GMXR, PRTS) 3:35 p.m. March 26, 2013 - 247WallSt.com
Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors 9:01 a.m. March 26, 2013 - Seeking Alpha
Opexa Therapeutics Poised For Breakout 10:39 a.m. March 12, 2013 - Seeking Alpha
Market Close: Today’s Big Winners & Losers (OSIR, END, APP, HCI, PTEK, RDIB, MELA, OPXA, ACUR, RWC) 4:56 p.m. March 6, 2013 - 247WallSt.com
Opexa Therapeutics Gets Attention From Institutions, Should It Get Yours? 3:22 p.m. Feb. 14, 2013 - Seeking Alpha
Top Gainers Technical Data -- Research on SolarCity, Clean Energy Fuel, Opexa Therapeutics, and Atossa Genetics 7:50 a.m. May 30, 2014 - PR Newswire - PRF
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg 8:38 a.m. May 29, 2014 - GlobeNewswire
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis 8:02 a.m. May 13, 2014 - BusinessWire - BZX
Opexa Therapeutics Announces News Release and Conference Call to Discuss First Quarter 2014 Financial Results 8:02 a.m. May 12, 2014 - BusinessWire - BZX
Global Stem Cell Umbilical Cord Blood (UCB) Market (Storage Service, Therapeutics, Application, Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 - 2020 12:33 p.m. April 23, 2014 - PR Newswire - PRF
Opexa Therapeutics to Attend the American Academy of Neurology Annual Meeting 8:01 a.m. April 22, 2014 - BusinessWire - BZX
RedChip Global Online CEO Conference, April 23-24, Featuring Presentations From 30+ Small-Cap Companies 10:24 a.m. April 21, 2014 - GlobeNewswire
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg 10:19 a.m. April 10, 2014 - GlobeNewswire
Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa 8:00 a.m. March 21, 2014 - PR Newswire - PRF
Opexa Therapeutics Appoints Prof. Hans-Peter Hartung and Timothy Barabe to the Board of Directors 8:02 a.m. March 20, 2014 - BusinessWire - BZX
Opexa Therapeutics Reports Year End 2013 Financial Results and Provides Corporate Update 5:20 p.m. Feb. 27, 2014 - BusinessWire - BZX
Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Year End 2013 Financial Results 9:02 a.m. Feb. 26, 2014 - BusinessWire - BZX
DELiA*s Path to Recovery Hampered By Sluggish Retail Marketplace 11:04 a.m. Feb. 24, 2014 - ACCESSWIRE
Opexa Therapeutics CEO to Present at the 2014 Leerink Global Healthcare Conference 3:17 p.m. Feb. 11, 2014 - BusinessWire - BZX
Opexa Therapeutics to Present at the 16th Annual BIO CEO & Investor Conference 10:00 a.m. Jan. 29, 2014 - BusinessWire - BZX
Opexa Therapeutics Chief Scientific Officer Invited as Guest Speaker at the Phacilitate Cell & Gene Therapy Forum 10:01 a.m. Jan. 23, 2014 - BusinessWire - BZX
Opexa Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 11:18 a.m. Dec. 23, 2013 - BusinessWire
Opexa Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock 10:15 p.m. Dec. 17, 2013 - BusinessWire
Opexa Therapeutics, Inc. Announces Proposed Public Offering of Common Stock 5:33 p.m. Dec. 17, 2013 - BusinessWire
Opexa Therapeutics Provides MS Trial Enrollment Update; 70% of Patients Enrolled 9:00 a.m. Dec. 16, 2013 - BusinessWire
(0)
(0)Scroll down for more posts ▼